Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07313514

The Value of the O-RADS Radiological Classification in Predicting the Malignancy of Ovarian Masses in Children

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
1 Year – 16 Years
Healthy volunteers
Not accepted

Summary

When faced with an ovarian mass in a girl, conservative surgery (resection of the mass while preserving healthy ovarian tissue) via laparoscopy remains the most appropriate treatment option. However, this option is no longer indicated for malignant tumors, as this presents a risk of tumor dissemination that can significantly alter the child's subsequent prognosis. Therefore, for any malignant or suspected malignant tumor, radical treatment consisting of oophorectomy or salpingo-oophorectomy, often via laparotomy, is the standard. While keeping this therapeutic principle in mind, differentiating between benign and malignant entities remains the major challenge for clinicians. Furthermore, the diagnostic accuracy of the O-RADS classification based on MRI is not sufficiently established in the literature for children. Our project aims to conduct a multicenter study in the pediatric population to investigate the usefulness of this radiological classification in the preoperative diagnosis of ovarian masses.

Conditions

Timeline

Start date
2025-03-11
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2026-01-02
Last updated
2026-01-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07313514. Inclusion in this directory is not an endorsement.